GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway

We previously demonstrated that treatment of the H295R adrenocortical cancer cell line with the non-steroidal, high-affinity GPER (G protein-coupled estrogen receptor 1) agonist G-1 reduced tumor growth in vitro and in vivo through a GPER independent action. Moreover, we observed that G-1 treatment...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Casaburi, Ivan, Avena, Paola, De Luca, Arianna, Sirianni, Rosa, Rago, Vittoria, Chimento, Adele, Trotta, Francesca, Campana, Carmela, Rainey, William E., Pezzi, Vincenzo
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777797/
https://ncbi.nlm.nih.gov/pubmed/29383185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23314
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky